Multiple Ascending Dose Study of DS-1093 in Healthy Subjects

NCT02142400 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaemia

Interventions

DRUG: DS-1093
DRUG: placebo

Sponsor

Daiichi Sankyo